Who is the CEO of Dimerix Limited?

The CEO of Dimerix Limited is Nina Webster M.IP.Law, MBA,.

What industry does Dimerix Limited belong to?

Dimerix Limited operates in the Biotechnology industry within the Healthcare sector.

Where is Dimerix Limited headquartered?

Dimerix Limited is headquartered at 425 Smith Street, Fitzroy, VIC, 3065, AU.

What is the IPO date of Dimerix Limited?

Dimerix Limited went public on July 31, 1989.

How many employees does Dimerix Limited have?

The total number of employees at Dimerix Limited is disclosed periodically in the company's annual financial reports.

Dimerix Limited

DXB.AX•ASX

Healthcare

Biotechnology

A$0.48

A$0.01(2.13%)

Dimerix Limited (DXB.AX) Company Profile & Overview

Explore Dimerix Limited’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Dimerix Limited (DXB.AX) Company Profile & Overview

Dimerix Limited, a biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs. It develops DMX-200 that is in two Phase 3 clinical trials for COVID respiratory complications; DMX-200, a Phase 3 clinical trial for focal segmental glomerulosclerosis disease; DMX-200 for diabetic kidney disease; and DMX-700 for chronic obstructive pulmonary disease. The company is headquartered in Fitzroy, Australia.

SectorHealthcare

IndustryBiotechnology

CEONina Webster M.IP.Law, MBA,

Contact Information

https://dimerix.com

1300 813 321

425 Smith Street, Fitzroy, VIC, 3065

Company Facts

IPO DateJul 31, 1989

CountryAU

Actively Trading

Frequently Asked Questions

;